Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the Netherlands / NCT06899009
Active, not recruiting Observational

Ventilator Settings and Outcomes in Pediatric Patients on ECMO for Severe Respiratory Failure

NCT06899009 · tracked via the Priya Life Science Netherlands tracker
Sponsor
University Medical Center Groningen
Phase
Observational
Started
2024-09-01
Last updated
2025-03-27

Condition(s) studied

Critical IllnessRespiratory Failure (Pediatric Patients)

Study summary

This study aims to describe the effects of ECMO initiation on the intensity of ventilation in the first 24 hours after ECMO initiation and to explore associations between changes in ventilation intensity and hospital mortality in critically ill pediatric patients requiring ECMO for respiratory failure, using the 'Extracorporeal Life Support Organization' (ELSO) registry.

Eligibility

Sex
ALL
Min age
29 Days
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients (aged ≥29 days to ≤18 years) receiving ECMO between January 1, 2012, and December 31, 2022, in an ELSO affiliated center; and 2. Requiring ECMO for a pulmonary indication. Exclusion Criteria: 1. Patients with missing ventilatory variables required to assess ventilation intensity; 2. patients who were lost to follow up with respect to hospital mortality.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Medical Center Groningen Groningen Netherlands

More University Medical Center Groningen trials in the Netherlands

Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection Recruiting
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas Recruiting
Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation Recruiting
Cardiopulmonary Toxicity of Thoracic Radiotherapy Recruiting
Change in Task-related Oxygen Uptake After EBV Treatment Recruiting

Other trials for the same condition

PRactice of VENTilation in Critically Ill PEDiatric Patients Recruiting
The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Critically Ill Patients Recruiting
PRotEin Provision in Critical IllneSs -2 Starting soon
Calibration of Esophageal Balloon Catheter in Spontaneous and Mandatory Mechanical Ventilation Recruiting
Surface Electrical Myography, Oxygen Consumption, Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06899009 on ClinicalTrials.gov ↗ ← All trials in the Netherlands